Macquarie Group LTD Fortress Biotech, Inc. Transaction History

Macquarie Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$1.26 - $1.96 $13,968 - $21,728	-11,086 Reduced 9.98%	100,000 $141,000
Q2 2019 Aug 14, 2019	BUY	$1.43 - $1.94 $158,852 - $215,506	111,086 New	111,086 $167,000
Q1 2019 May 15, 2019	SELL	$0.94 - $2.47 $30,796 - $80,922	-32,762 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$0.57 - $1.53 $14,481 - $38,871	-25,406 Reduced 43.68%	32,762 $28,000
Q3 2018 Nov 15, 2018	SELL	$1.44 - $3.13 $57,332 - $124,617	-39,814 Reduced 40.63%	58,168 $93,000
Q2 2018 Aug 14, 2018	BUY	$2.92 - $5.1 $149,212 - $260,609	51,100 Added 109.0%	97,982 $292,000
Q1 2018 May 11, 2018	BUY	$3.42 - $5.35 $145,972 - $228,348	42,682 Added 1016.24%	46,882 $213,000
Q4 2017 Feb 15, 2018	BUY	$3.26 - $4.84 $13,692 - $20,328	4,200	4,200 $17,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $173M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.